Randomized phase II pilot study of loratadine for the prevention of bone pain caused by pegfilgrastim.
- Citation:
- J Clin Oncol vol 32 (5s) abstr 9628
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- ClinicalTrials.gov Identifier: NCT01311336 http://clinicaltrials.gov/ct2/show/record/NCT01311336
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2365